Bristol Myers Squibb Co (BMY) - Comprehensive Stock Analysis & Investment Research
Deep dive into Bristol Myers Squibb Co's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Bristol Myers Squibb Co Investment Summary
When evaluating whether Bristol Myers Squibb Co (BMY) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Bristol Myers Squibb Co (BMY) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $126 billion, the company is a large-cap stock offering relative stability combined with growth potential.
Financial Performance Analysis
Our comprehensive financial analysis covers Bristol Myers Squibb Co's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Bristol Myers Squibb Co along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Bristol Myers Squibb Co is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Bristol Myers Squibb Co (Stock Symbol: BMY) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Bristol Myers Squibb Co's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Bristol Myers Squibb Co...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Bristol Myers Squibb Co...
Revenue & Growth Analysis
Bristol Myers Squibb Co generates annual revenues of $49 billion , demonstrating substantial market presence and operational scale.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Bristol Myers Squibb Co...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Bristol Myers Squibb Co...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Bristol Myers Squibb Co...
Strategic Market Position
Bristol Myers Squibb Co strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.
Industry Competitive Landscape
Bristol Myers Squibb Co competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company demonstrates exceptional operational efficiency through free cash flow generation of $11 billion annually , with year-over-year cash flow growth of -19.6%. This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.
Margin & Pricing Power Analysis
The company maintains a 70.2% gross margin which reflects strong pricing power and/or low direct production costs relative to revenue. Gross margins are only comparable within an industry, so read this level against the company's peers rather than the market as a whole.
Asset Utilization Efficiency
Asset turnover ratio of 0.56x indicates moderate asset turnover. Lower turnover is expected where the business model requires significant infrastructure, so the ratio should be read against the company's own industry.
Financial Strength & Leverage
Current ratio of 1.53 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.